Metropolitan Life Insurance Company (MetLife)’s SkinHealth Systems SKIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,945
Closed -$13.1K 1780
2024
Q1
$13.1K Buy
2,945
+323
+12% +$1.05K ﹤0.01% 2035
2023
Q4
$8.15K Sell
2,622
-2,197
-46% -$8.24K ﹤0.01% 2239
2023
Q3
$29K Hold
4,819
﹤0.01% 1700
2023
Q2
$40.3K Hold
4,819
﹤0.01% 1558
2023
Q1
$60.9K Sell
4,819
-1,606
-25% -$18.6K ﹤0.01% 1283
2022
Q4
$58.5K Buy
6,425
+628
+11% +$6.78K ﹤0.01% 1371
2022
Q3
$68.3K Hold
5,797
﹤0.01% 1248
2022
Q2
$74.5K Hold
5,797
﹤0.01% 1243
2022
Q1
$97.9K Sell
5,797
-17,710
-75% -$292K ﹤0.01% 1206
2021
Q4
$568K Hold
23,507
0.01% 1337
2021
Q3
$610K Buy
23,507
+9,068
+63% +$199K 0.01% 1317
2021
Q2
$243K Buy
+14,439
New +$197K ﹤0.01% 2011

Other funds holding SKIN

Metropolitan Life Insurance Company (MetLife)'s SKIN Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of SkinHealth Systems (SKIN) in Q2 2024, closing a stake of 2,945 shares — an estimated $13.1K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in SKIN in Q2 2021 and held it in 12 quarters. The position peaked at $610K in Q3 2021. 116 funds tracked by Wall St. Rank hold SKIN as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining SkinHealth Systems position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,945 SkinHealth Systems shares in Q2 2024, an estimated $13.1K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in SkinHealth Systems in Q2 2021 and held it in 12 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s SkinHealth Systems position peaked at $610K in Q3 2021.
  • 116 funds tracked by Wall St. Rank held SkinHealth Systems as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.